Marshall Wace’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-500
Closed -$233K 3414
2025
Q4
$233K Buy
+500
New +$232K ﹤0.01% 2542
2024
Q1
Sell
-36,500
Closed -$9.88M 2588
2023
Q4
$9.88M Buy
+36,500
New +$9.02M 0.02% 694
2017
Q1
Sell
-88,900
Closed -$7.44M 489
2016
Q4
$7.44M Buy
+88,900
New +$6.66M 0.05% 389

Other funds holding HCA

Marshall Wace's HCA Position: Q1 2026 in Review

Marshall Wace reduced its HCA Healthcare (HCA) stake by 30% in Q1 2026, selling an estimated $9.56M and leaving 44,059 shares worth $20.9M. The position accounts for 0.02% of the portfolio, ranked #691.

Marshall Wace first reported a position in HCA in Q2 2014 and has held it in 28 quarters since. The position peaked at $52M in Q4 2019. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Marshall Wace held 44,059 shares of HCA Healthcare worth $20.9M as of Q1 2026.
  • Marshall Wace sold 18,983 HCA Healthcare shares in Q1 2026, an estimated $9.56M.
  • HCA Healthcare made up 0.02% of Marshall Wace's portfolio in Q1 2026, its #691 holding.
  • Marshall Wace first reported a position in HCA Healthcare in Q2 2014 and has held it in 28 quarters since.
  • Marshall Wace's HCA Healthcare position peaked at $52M in Q4 2019.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.